Navigation Links
Super-sized world: Conference addresses global obesity epidemic, explores policies, interventions
Date:11/29/2010

A conference at the New York Academy of Sciences on December 9 will convene leading obesity researchers to explore the latest science and policy initiatives addressing the global and national health crisis of obesity. The half-day event, Super-sized World: The Global Obesity Epidemic, is presented by the Academy and the Johns Hopkins Bloomberg School of Public Health with support from the new Sackler Institute for Nutrition Science.

More than one billion adults worldwide are overweight and nearly 300 million are clinically obese, according to the World Health Organization. Obesity is a major contributor to the global burden of chronic disease and disability as a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and certain forms of cancer. Once thought to be a problem affecting only industrialized, developed countries, obesity and obesity-related diseases are increasingly prevalent in the developing world.

Speakers Benjamin Caballero, MD, PhD, of Johns Hopkins Bloomberg School of Public Health, and Jeanne Clark, MD, MHS, of Johns Hopkins University School of Medicine, will give the global and domestic perspectives on obesity, respectively.

Kelly D. Brownell, PhD, of Yale University, will present "The Final Frontier: Is There the Courage to Change Policy," and Keshia M. Pollack, PhD, MPH, of Johns Hopkins Bloomberg School of Public Health, will present "Interventions: Successes, Opportunities, and Challenges."

Robert S. Lawrence, MD, Johns Hopkins Bloomberg School of Public Health, will moderate a panel discussion. A reception will follow the event.

Super-sized World: The Global Obesity Epidemic, takes place from 12:00 6:00 PM on Thursday, December 9, 2010, at the New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY.

Registration is $35. Academy members are admitted free. Register online at www.
'/>"/>

Contact: Adrienne Burke
aburke@nyas.org
New York Academy of Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Myth of a germ-free world: A closer look at antimicrobial products
2. Life-saving in the bacterial world: How Campylobacter rely on Pseudomonas to infect humans
3. Out of this world: New study investigates infection of human cells in space
4. CSI in a virtual world: New grant furthers NC States work in forensic science
5. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
6. Regenerative medicine workshops to debut at TERMIS North America Annual Conference
7. Worldwide press room opens for major acoustical science and technology conference, Nov. 15-19
8. UC doctoral student presents research at international conference
9. BIO-key® Announces Third Quarter 2010 Earnings Release and Conference Call Schedule
10. Highlights from major acoustical science and technology conference, Nov. 15-19
11. International Conference on Biotherapy to be held in the US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), ... general the State of Washington,s Department ... new enrollment and central issuance system for driver,s licenses and ... The project planning and development will start in January 2015, ...
(Date:1/22/2015)... DETROIT , Jan. 13, 2015 Technology Showcase, Hall ... iris-based identity authentication solutions, today announced it will showcase its ... and developed by the Department of Energy,s Oak Ridge ... International Auto Show . EyeLock,s iris identity authentication technology is ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric ... recent success of the Wocket™ smart wallet at CES 2015 in ... named as one of the "11 Hot Products at CES" in a ... CES So Far" by Newseveryday.com and "The top 10 gadgets from CES ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... known as marine protected areas provide many direct benefits ... zones appear to offer limited help to corals in ... study. To protect coral reefs from climate change, ... that can meaningfully reduce greenhouse gas emissions, researchers said. ...
...  AnaptysBio, Inc., a privately held therapeutic antibody company, today ... Michael Gallatin, Ph.D. to the company,s Therapeutic Advisory Board ... members of AnaptysBio,s TAB, Jan de Vries, Ph.D. and ... http://photos.prnewswire.com/prnh/20111205/SF16052LOGO ) AnaptysBio,s TAB is constituted to ...
... and Stanford University are expanding EteRNA a unique research ... that are then tested in a laboratory thanks to ... additions already implemented is a new puzzle in which players ... the presence of other molecules. , A $1 million grant ...
Cached Biology News:Rising ocean temperatures harm protected coral reefs 2Rising ocean temperatures harm protected coral reefs 3AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board 2AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board 3AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board 4Keck award enables Carnegie Mellon and Stanford to dramatically expand crowdsourced RNA design 2
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... San Francisco, CA (PRWEB) February 27, 2015 ... is joining forces on February 28 with patients and ... to raise awareness for Rare Disease Day®. Rare ... rare diseases and calling attention to the special challenges ... community around them. , “Cytokinetics is proud to stand ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  23andMe, the ... Kate Black as Privacy Officer and Corporate ... and state privacy laws as well as health care ... team, she will be responsible for reviewing, updating and ... in the U.S. and abroad. She joined the company ...
(Date:2/26/2015)... Fla. , Feb. 26, 2015 DuPont ... growth priorities driven by key research advancements and product ... at today,s Bank of America Merrill Lynch 2015 Global ... the challenge of building grain supplies the last two ... continue at the pace of the last decade, when ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... China, Oct. 27 /Xinhua-PRNewswire/ -- Recently, China ... State Intellectual,Property Office for two patents for ... Materials and Industrialized Production,Method of Fully Biodegradable ... patent applications have both obtained acceptance numbers,200810064592 ...
... Oct. 27 Trubion Pharmaceuticals Inc.,(Nasdaq: ... a Phase 1/2a study,demonstrating that repeat administration ... significant improvements in rheumatoid arthritis,(RA) signs and ... (ACR),criteria. Trubion also announced positive results following ...
... Biosciences, Inc. ("Carna"),announced on October 27, 2008, the ... Company ("SUBC"). Under the terms of this,Agreement, SUBC ... within China., With China,s emergence as a ... biopharmaceutical companies have now established,research and production facilities ...
Cached Biology Technology:Patent Technologies Keep CGMT in a Leading Position in the Industry 2Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 2Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 3Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 4Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 5Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company 2
...
PURA Immunogen: PURA (NP_005850, 183 a.a. ~ 293 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: